Hepatología – Enfermedades Inflamatorias Intestinales

Investigador Responsable

– Juan Turnes Vázquez MD, PhD, Hepatología

Investigadores Residentes

– Jesús Castro Pérez MD, Hepatología

– Manuel Puga Giménez de Azcárate MD, Hepatología

Investigadores Colaboradores

– Victoria Álvarez Sánchez MD, Hepatología

– Daniel Carpio Lopez MD, Hepatología

– David Carral Martínez MD, Hepatología

– Enrique González de la Ballina González MD, Hepatología

– José Manuel Mera Calviño MD, Hepatología

– Raquel Souto Rodríguez MD, Hepatología

– José Luis Ulla Rocha MD, PhD, Hepatología

– Javier Vázquez San Luis MD, Hepatología

Técnicos

– Mª José Rodríguez Otero, Enfermería

Personal de gestión

– Sandra Daponte Angueira, Gestión de Proyectos

Hepatitis virales; Complicaciones de la cirrosis hepática; Hepatocarcinoma; Esteatohepatitis no alcohólica

1. Hepatitis virales.
2. Complicaciones de la cirrosis hepática.
3. Hepatocarcinoma.
4. Esteatohepatitis no alcohólica.

Artículos Científicos

1. Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, Gonzalez-Garcia J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, Garcia-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Sola R. Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study. PLoS One. 2015 Jan;10(3):e0122613. PMID: 25826755. IF: 3.234; Q1. +Info http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4426774&tool=pmcentrez&rendertype=abstract
2. Turnes J, Díaz R, Hernandez-Guerra M, Gómez M, Castells L, Bustamante J, Espinosa MD, Fernández-Castroagudín J, Serrano T, Rendón P, Andrade R, Salgado M, Arenas J, Vergara M, Sala M, Polo BA, Granizo IM, Gonzálvez ML, Viudez A. [Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain]. Gastroenterol Hepatol. 2015 Apr;38(4):263–73. PMID: 25583146. IF: 0.838; Q4. +Info http://www.ncbi.nlm.nih.gov/pubmed/25583146
3. Hernández-Guerra M, Hernández-Camba A, Turnes J, Ramos LM, Arranz L, Mera J, Crespo J, Quintero E. Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival. United Eur Gastroenterol J. 2015 Jun;3(3):284–93. PMID: 26279838. IF: 2.080; Q3. +Info http://www.ncbi.nlm.nih.gov/pubmed/26279838
4. 4. Daniele B, Croitoru A, Papandreou C, Bronowicki J-P, Mathurin P, Serejo F, Stål P, Turnes J, Ratziu V, Bodoky G. Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study. Future Oncol. Future Medicine Ltd London, UK; 2015 Jul;1–10. PMID: 26158398. IF: 2.477; Q3. +Info http://www.ncbi.nlm.nih.gov/pubmed/26158398

Artículos Científicos

1. Alvarez-Sánchez MV, Jenssen C, Faiss S, Napoléon B. Interventional endoscopic ultrasonography: an overview of safety and complications. Surg Endosc. Springer US; 2014 Mar;28(3):712–34. PMID: 24196551. IF: 3.256; Q1. +Info
2. Albillos A, Luis Calleja J, Molina E, Planas R, Romero-Gómez M, Turnes J, Hernández-Guerra M. [Chronic hepatitis C: patients with mild disease]. Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:13–22. PMID: 25907434. IF: 0.838; Q4. +Info
3. Buti M, Gros B, Oyagüez I, Andrade RJ, Serra MA, Turnes J, Casado MA. [Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]. Farm Hosp. 2014 Sep;38(5):418–29. PMID: 25344136. N/A; N/A. +Info
4. Souto-Rodríguez R, Molina-Pérez E, Castroagudín JF, Fernández Pérez A, Otero-Antón E, Tomé Martínez de Rituerto S, Martínez-Castro J, Varo-Pérez E. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol. Transplant Proc. 2014 Nov;46(9):3117–20. PMID: 25420839. IF: 0.952; Q3. +Info
5. Alvarez-Sánchez M-V, Napoléon B. Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J Gastroenterol. 2014 Nov;20(42):15549–63. PMID: 25400439. IF: 2.369; Q3. +Info
6. Ulla-Rocha JL, Lopez-Piñeiro S, Puga-Gimenez M. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan.]. Gastroenterol Hepatol. 2014 Dec;([Epub ahead of print]) PMID: 25534549. IF: 0.838; Q4. +Info